<em>FBLN4</em> as candidate gene associated with long-term and short-term survival with primary glioblastoma

Abstract

To our knowledge, this is the first report describing <i>FBLN4</i> as a prognostic factor for GBM patient survival, demonstrating that increased GBM survival time correlates with decreased <i>FBLN4</i> expression. Understanding <i>FBLN4</i> expression patterns could aid in the creation of powerful tools to predict clinical prognoses of GBM patients.